Sirius Investors
28.34
1.12%Today
MRNAModerna, Inc. • NASDAQ Global Select • Healthcare
Market Cap
11.02B
Volume
3.05M
52W High
91.99
52W Low
23.15

Company Overview

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Company Information

CEO
Stephane Bancel
Sector
Healthcare
Industry
Biotechnology
Employees
5800

Contact Information

Address
200 Technology Square
Country
US

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 11.02B market capitalization
  • Trading Volume: 3.05M shares traded today
  • Price Range: 52-week range of $23.15 - $91.99
  • Exchange: Listed on NASDAQ Global Select

Financial Metrics

P/E Ratio:-3.77
EPS:$-7.51
Beta:1.83
Avg Volume:10.34M

Market Analysis for Moderna, Inc.

Moderna, Inc. (MRNA) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 11.02B, the company represents a significant player in its market. The stock is currently trading at $28.34 with a positivedaily change of 1.12%.

The company's 5800 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -3.77, beta of 1.83, and 52-week price range from $23.15 to $91.99when evaluating investment opportunities.

Why Invest in Moderna, Inc.?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (NASDAQ Global Select)
  • • Experienced leadership under Stephane Bancel
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Healthcare Stocks

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.